Both UCLA Health and Healthline highlight research where people with Peripheral Artery Disease (PAD) improved their pain-free walking distance with glutathione
Cornu M, Modi H, Kawamori D, Kulkarni RN, Joffraud M, Thorens B: Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression
It is also hard to predict how people will think about these drugs over the long term, with a recent study by The New Consumer and Coefficient Capital showing that 46% of 1,810 consumers aware of GLP-1 weight loss drugs are extremely or very concerned about their long-term health impact, a figure that rises to 51% among users of such drugs (n-388)
Studies on periodontal disease models show the peptide significantly reduced plasma extravasation, histological alterations, and alveolar bone resorption